NCT06244654

Brief Summary

Regional anesthesia allows surgery without affecting the patient's level of consciousness.However, this may cause anxiety in some patients.In previous research, scientists have tried to prevent anxiety with non-pharmacological interventions such as music and cognitive therapies.Virtual reality is thought to offer an immersive experience that can alter the mind's perception of pain. Scientists have found in previous preliminary studies that virtual reality is safe and effective as an adjunct to standard sedative/analgesic protocols for reducing patients' pain and anxiety during endoscopy, colonoscopy, dental treatments, burn dressings, and labor. In this study, it is expected that anxiety scores, postoperative analgesic need and intraoperative sedation need will decrease, recovery quality will improve and patient satisfaction will increase in patients who will undergo upper extremity surgery under regional anesthesia and watch videos through VR glasses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
86

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 19, 2024

Completed
6 days until next milestone

Study Start

First participant enrolled

January 25, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 6, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2024

Completed
Last Updated

January 6, 2025

Status Verified

January 1, 2025

Enrollment Period

5 months

First QC Date

January 19, 2024

Last Update Submit

January 3, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • State-Trait Anxiety Scale

    preoperative and postoperative STAI I and II score questions will be asked.

    Preoperative, Postoperative 4.hour

Secondary Outcomes (10)

  • systolic blood pressure

    Preoperative, İntraoperative 0 min, İntraoperative 60min, End of Operation, Postoperative 4.hour

  • diastolic blood pressure

    Preoperative, İntraoperative 0 min, İntraoperative 60min, End of Operation, Postoperative 4.hour

  • mean arterial pressure

    Preoperative, İntraoperative 0 min, İntraoperative 60min, End of Operation, Postoperative 4.hour

  • heart rate

    Preoperative, İntraoperative 0 min, İntraoperative 60min, End of Operation, Postoperative 4.hour

  • oxygen saturation

    Preoperative, İntraoperative 0 min, İntraoperative 60min, End of Operation, Postoperative 4.hour

  • +5 more secondary outcomes

Study Arms (2)

Standart Anesthesia management

OTHER

In the non-VR group, the standard anesthesia procedure will be followed. Brachial plexus nerve block will be performed with a 50mm peripheral block needle (Vygon echoplex+ 22Gx50mm) with a mixture of 2% lidocaine and 0.5% bupivacaine (10 mL each) prepared as 20ml. After waiting for a sufficient time, the nerve block effectiveness of the patients will be measured by Modified Broomage scale and pinprick. Additional sedative agents may be applied to both groups at the discretion of the anesthesiologist and will be recorded. Anesthesia management will be applied to both groups in accordance with the standard working order of the Anesthesia clinic.

Other: No VR

VR group

EXPERIMENTAL

Oculus Quest 2 VR virtual reality glasses and wired over-ear headphones will be used for patients to hear the sounds of the immersive environment and to block the sounds coming from the operating room environment. Brachial plexus nerve block will be performed with a 50mm peripheral block needle (Vygon echoplex+ 22Gx50mm) with a mixture of 2% lidocaine and 0.5% bupivacaine (10 mL each) prepared as 20ml. After waiting for a sufficient time, the nerve block effectiveness of the patients will be measured by Modified Broomage scale and pinprick.Additional sedative agents may be applied to both groups at the discretion of the anesthesiologist and will be recorded. Anesthesia management will be applied to both groups in accordance with the standard working order of the Anesthesia clinic.

Device: Oculus Quest 2 VR virtual reality glasses and wired over-ear headphones

Interventions

After the VR group comes to the preoperative area and is evaluated, they will be asked to wear VR glasses and headphones. VR glasses and headphones were worn on the patient during peripheral nerve block applications and the operation. At the end of the operation, the VR glasses and headphones were removed and they were taken to the postoperative recovery room.

VR group
No VROTHER

After evaluation of the patients taken to the preoperative area, routine peripheral nerve block application was performed without the use of VR glasses. VR glasses were not worn during the operation, as is the routine protocol. At the end of the surgery, they were taken to the postoperative recovery room.

Also known as: Control group
Standart Anesthesia management

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • who will undergo upper extremity surgery under regional anesthesia

You may not qualify if:

  • being under 18 years old
  • Those who do not have the ability to read, understand and sign the consent form
  • An active infection or open wound in the face or eye area
  • History of seizures due to an epileptic condition or any other reason
  • Planning to wear a hearing aid during the surgical procedure
  • Having a pacemaker or other implanted medical device
  • Migraine
  • Having an infectious condition that is transmitted through droplets or airborne
  • not knowing Turkish
  • Not deemed suitable for the approach by the surgeon
  • History of psychosis or claustrophobia
  • Being visually and/or hearing impaired

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara City Hospital

Ankara, Cankaya, Turkey (Türkiye)

Location

Related Publications (3)

  • Moon JY, Shin J, Chung J, Ji SH, Ro S, Kim WH. Virtual Reality Distraction during Endoscopic Urologic Surgery under Spinal Anesthesia: A Randomized Controlled Trial. J Clin Med. 2018 Dec 20;8(1):2. doi: 10.3390/jcm8010002.

    PMID: 30577461BACKGROUND
  • Barry KS, Nimma SR, Spaulding AC, Wilke BK, Torp KD, Ledford CK. Perioperative Outcomes of Immersive Virtual Reality as Adjunct Anesthesia in Primary Total Hip and Knee Arthroplasty. Arthroplast Today. 2022 Oct 22;18:84-88. doi: 10.1016/j.artd.2022.09.015. eCollection 2022 Dec.

    PMID: 36312886BACKGROUND
  • Alaterre C, Duceau B, Sung Tsai E, Zriouel S, Bonnet F, Lescot T, Verdonk F. Virtual Reality for PEripheral Regional Anesthesia (VR-PERLA Study). J Clin Med. 2020 Jan 13;9(1):215. doi: 10.3390/jcm9010215.

    PMID: 31941129BACKGROUND

MeSH Terms

Conditions

Anxiety DisordersPain, Postoperative

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Mental DisordersPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant professor

Study Record Dates

First Submitted

January 19, 2024

First Posted

February 6, 2024

Study Start

January 25, 2024

Primary Completion

June 30, 2024

Study Completion

July 15, 2024

Last Updated

January 6, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations